BMS calls time on Zymeworks collab, ending work on phase 1 cancer bispecific
BMS calls time on Zymeworks collab, ending work on phase 1 cancer bispecific
BMS calls time on Zymeworks collab, ending work on phase 1 cancer bispecific
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.